Evidence map›Paper›PMID 26288817›Full record

ArticleEBioMedicine2015

GLI3 Links Environmental Arsenic Exposure and Human Fetal Growth.

Emily F Winterbottom, Dennis L Fei, Devin C Koestler, Camilla Giambelli, Eric Wika, Anthony J Capobianco, Ethan Lee, Carmen J Marsit, Margaret R Karagas, David J Robbins

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Emily F WinterbottomMolecular Oncology Program, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Dennis L FeiMolecular Oncology Program, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
Devin C KoestlerDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Camilla GiambelliMolecular Oncology Program, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Eric WikaDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Anthony J CapobiancoMolecular Oncology Program, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; Molecular Oncology Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Ethan LeeDepartment of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Carmen J MarsitDepartment of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA ; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
Margaret R KaragasDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
David J RobbinsMolecular Oncology Program, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA ; Molecular Oncology Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Dartmouth College · USSylvester Comprehensive Cancer Center · USUniversity of Kansas Medical Center · USMolecular Oncology (United States) · USUniversity of Miami · USVanderbilt University Medical Center · US

Funding

Project 3: Placental Biomarkers of Exposure and Outcome (Marsit)P01ES022832 · NIEHS · DARTMOUTH COLLEGE · PI MURRAY, CAROLYN J · 2013 to 2018
$4.7M
Regulation of beta-catenin degradation during Wnt signal transductionR01GM081635 · NIGMS · VANDERBILT UNIVERSITY · PI LEE, ETHAN · 2007 to 2016
$2.4M
Role of ubiquitination in the Wnt pathwayR01GM103926 · NIGMS · VANDERBILT UNIVERSITY · PI LEE, ETHAN · 2013 to 2016
$1.2M
NIEHS NIH HHS P01 ES022832NIGMS NIH HHS R01 GM081635NIGMS NIH HHS R01 GM103926
6 · The paper itself

Abstract

Although considerable evidence suggests that in utero arsenic exposure affects children's health, these data are mainly from areas of the world where groundwater arsenic levels far exceed the World Health Organization limit of 10 μg/L. We, and others, have found that more common levels of in utero arsenic exposure may also impact children's health. However, the underlying molecular mechanisms are poorly understood. To address this issue, we analyzed the expression of key developmental genes in fetal placenta in a birth cohort of women using unregulated water supplies in a US region with elevated groundwater arsenic. We identified several genes whose expression associated with maternal arsenic exposure in a fetal sex-specific manner. In particular, expression of the HEDGEHOG pathway component, GLI3, in female placentae was both negatively associated with arsenic exposure and positively associated with infant birth weight. This suggests that modulation of GLI3 in the fetal placenta, and perhaps in other fetal tissues, contributes to arsenic's detrimental effects on fetal growth. We showed previously that arsenic-exposed NIH3T3 cells have reduced GLI3 repressor protein. Together, these studies identify GLI3 as a key signaling node that is affected by arsenic, mediating a subset of its effects on developmental signaling and fetal health.

Indexed as

AdolescentAdultArsenicBirth WeightChild HealthEnvironmental ExposureFemaleFetal DevelopmentGene Expression ProfilingGroundwaterHumansKruppel-Like Transcription FactorsMaternal ExposureMiddle AgedNerve Tissue ProteinsOctamer Transcription Factor-3ArsenicGLI3 protein, humanKruppel-Like Transcription FactorsNerve Tissue ProteinsOctamer Transcription Factor-3POU5F1 protein, humanWater Pollutants, ChemicalZinc Finger Protein Gli3ArsenicAs, arsenicBirth WeightCI, confidence intervalDevelopmentGLI3HH, HEDGEHOGIQR, interquartile rangeMCL, maximum contaminant levelPlacentaSexU-As, total urinary arsenic concentration

Identifiers

PMID26288817
PMCPMC4535308
OpenAlexW2157149147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.